Uncovering a neurological protein signature for severe COVID-19

<p dir="ltr">Coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has sparked a global pandemic with severe complications and high morbidity rate. Neurological symptoms in COVID-19 patients, and neurological sequelae post COV...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Omar El-Agnaf (2134222) (author)
مؤلفون آخرون:	Ilham Bensmail (12204845) (author), Maryam A.Y. Al-Nesf (15468644) (author), James Flynn (240802) (author), Mark Taylor (65647) (author), Nour K. Majbour (8809316) (author), Ilham Y. Abdi (14778898) (author), Nishant N. Vaikath (2901785) (author), Abdulaziz Farooq (5345384) (author), Praveen B. Vemulapalli (15468652) (author), Frank Schmidt (207186) (author), Khalid Ouararhni (3145734) (author), Heba H Al-Siddiqi (12204889) (author), Abdelilah Arredouani (14070786) (author), Patrick Wijten (2029159) (author), Mohammed Al-Maadheed (12204886) (author), Vidya Mohamed-Ali (12204895) (author), Julie Decock (44558) (author), Houari B. Abdesselem (14152827) (author)
منشور في:	2023
الموضوعات:	Biological sciences Biochemistry and cell biology Biomedical and clinical sciences Cardiovascular medicine and haematology Neurosciences Severe COVID-19 Neurological complications Olink proteomics Protein signature Neurological Disorders Research Center (QBRI) Translational Cancer and Immunity Center (QBRI) Diabetes Research Center (QBRI) FIFA Medical Centre of Excellence Doha, Qatar (Aspetar)
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Uncovering a neurological protein signature for severe COVID-19

مواد مشابهة